Clincosm LogoSign in Get a demo

esophageal squamous cell cancer

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

Recruiting
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Esophageal Cancer, Esophageal Adenocarcinoma, Esophageal Squamous Cell Cancer Trial run by the NCI (Chemoradiotherapy,

Terminated
Has Results
  • Esophageal Cancer
  • +4 more
  • Chemoradiotherapy
  • Esophagectomy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 3, 2018

Esophageal Squamous Cell Cancer Trial in Mainz (Cisplatin, 5-FU, Panitumumab)

Terminated
  • Esophageal Squamous Cell Cancer
  • Mainz, Rheinland-Pfalz, Germany
    Johannes-Gutenberg-Universität Mainz, I. Medizinische Klinik und
Mar 1, 2018

Esophageal Squamous Cell Cancer Trial in Beijing (Sequential chemo (paclitaxel 175mg/m2 d1; cisplatin 37.5mg/m2 d1,d2) and

Unknown status
  • Esophageal Squamous Cell Cancer
  • Sequential chemotherapy (paclitaxel 175mg/m2 d1; cisplatin 37.5mg/m2 d1,d2) and radiotherapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Dec 13, 2013

Esophageal Squamous Cell Cancer, Elderly Patients Trial in Beijing (Sequential chemo (paclitaxel 80mg/m2 d1,d8) and

Unknown status
  • Esophageal Squamous Cell Cancer
  • Elderly Patients
  • Sequential chemotherapy （paclitaxel 80mg/m2 d1,d8) and radiotherapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Dec 13, 2013

Esophageal Squamous Cell Cancer Trial in Beijing (nimotuzumab)

Unknown status
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Nov 20, 2013

Esophageal Squamous Cell Cancer Trial in Beijing (Nimotuzumab)

Unknown status
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Xiaodong Zhang
Apr 14, 2011